Bernard Caillou

Summary

Affiliation: Institut Gustave Roussy
Country: France

Publications

  1. ncbi Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma
    Anne Bachelot
    Institut Gustave Roussy, Villejuif, France
    Thyroid 12:707-11. 2002
  2. ncbi Ductal metaplasia in chronic lymphocytic thyroiditis as a manifestation of phylogenic regression to an exocrine structure
    Bernard Caillou
    Department of Pathology, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    Am J Surg Pathol 30:774-81. 2006
  3. ncbi Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer
    Sophie Leboulleux
    Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif Cedex, France
    J Clin Endocrinol Metab 92:3590-4. 2007
  4. ncbi Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer
    Claudia Scollo
    Nuclear Medicine, Institut Gustave Roussy, 94805 Villejuif Cedex, France
    J Clin Endocrinol Metab 88:2070-5. 2003
  5. ncbi Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment
    Anne Bachelot
    Department of Nuclear Medicine and Endocrine Tumours, Institut Gustave Roussy, Villejuif Cedex, France
    Clin Endocrinol (Oxf) 62:376-9. 2005
  6. ncbi Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis
    Sophie Leboulleux
    Department of Nuclear Medicine and Endocrine Tumors, Institut National de la Santé et de la Recherche Médicale U605, Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif Cedex, France
    J Clin Endocrinol Metab 90:5723-9. 2005
  7. ncbi Functional characterization of human thyroid tissue with immunohistochemistry
    Antongiulio Faggiano
    Department of Pathology, Commissariat à l Energie Atomique LRC29V, Institut Gustave Roussy, University Paris Sud, Villejuif Cedex, France
    Thyroid 17:203-11. 2007
  8. ncbi Differential expression of galectin-3 in medullary thyroid carcinoma and C-cell hyperplasia
    Antongiulio Faggiano
    Department of Pathology, Commissariat à l Energie Atomique LRC29V, Institut Gustave Roussy, F 94805 Villejuif Cedex, France
    Clin Endocrinol (Oxf) 57:813-9. 2002
  9. ncbi Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy
    Renaud de Crevoisier
    Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France
    Int J Radiat Oncol Biol Phys 60:1137-43. 2004
  10. ncbi Radiation exposure and familial aggregation of cancers as risk factors for colorectal cancer after radioiodine treatment for thyroid carcinoma
    Carole Rubino
    National Institute of Public Health and Medical Research, INSERM, Unit 605, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Int J Radiat Oncol Biol Phys 62:1084-9. 2005

Collaborators

  • M J Schlumberger
  • E Baudin
  • Sophie Leboulleux
  • Antongiulio Faggiano
  • D M Hartl
  • Marc Colonna
  • Clarisse Dromain
  • Dominique M Elias
  • Elisabeth Adjadj
  • F de Vathaire
  • Ludovic Lacroix
  • Jean Paul Travagli
  • Anne Bachelot
  • Monique Talbot
  • Abir Al Ghuzlan
  • Jean Michel Bidart
  • Carole Rubino
  • Pasqualino Malandrino
  • Nicolas Bellon
  • Melania Pulcrano
  • Cécile Kedzia
  • Renaud de Crevoisier
  • Stephane Bardet
  • Marcel Ricard
  • Patrick Marandas
  • Claudia Scollo
  • Francesca Lombardo
  • Anne Françoise Cailleux
  • Jacques Young
  • Thierry de Baere
  • Philippe Chanson
  • Marine Castaing
  • Angelo Paci
  • Alain Virion
  • Houda Boukheris
  • Corinne Dupuy
  • Françoise Doyon
  • Stefan Michiels
  • Tahaa Moncef Abbas
  • Jean Pierre Levillain
  • Nadine Binart
  • Hugues Ripoche
  • Akhtar Shamsaldin
  • Paul A Kelly
  • Christiane Langlois
  • Thierry Ragot
  • Philippe Dessen
  • Nabahet Ameur
  • Claudia Cecarreli
  • Vladimir Lazar
  • Claire Schvartz
  • Claire Magnon
  • Caterina Mian
  • Tosak Intaraphairot
  • Thierry Pourcher
  • Thierry Barrier
  • Odile Casiraghi
  • Michel A Germain
  • Bernard Luboinski
  • Yves Cachin
  • Martine Garnault
  • Michele Klain
  • Moncef Abbas
  • Chiara Conte
  • Sebastiano Filetti
  • Bruno Dallapiccola
  • Dario Giuffrida
  • Eusebio Chiefari
  • Franco Arturi
  • Ibrahima Diallo
  • Akthar Shamsaldin

Detail Information

Publications21

  1. ncbi Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma
    Anne Bachelot
    Institut Gustave Roussy, Villejuif, France
    Thyroid 12:707-11. 2002
    ..Nevertheless, undetectable serum Tg should not be considered as a reliable criteria to exclude a minimal tumor burden in patients who have already been treated with (131)I...
  2. ncbi Ductal metaplasia in chronic lymphocytic thyroiditis as a manifestation of phylogenic regression to an exocrine structure
    Bernard Caillou
    Department of Pathology, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    Am J Surg Pathol 30:774-81. 2006
    ..In this study, we describe in lymphocytic autoimmune thyroiditis the appearance of ductal-like structures which displayed the features of ductal metaplasia...
  3. ncbi Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer
    Sophie Leboulleux
    Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif Cedex, France
    J Clin Endocrinol Metab 92:3590-4. 2007
    ..Neck ultrasonography (US) has become a keystone in the follow-up of patients with differentiated thyroid cancer...
  4. ncbi Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer
    Claudia Scollo
    Nuclear Medicine, Institut Gustave Roussy, 94805 Villejuif Cedex, France
    J Clin Endocrinol Metab 88:2070-5. 2003
    ....
  5. ncbi Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment
    Anne Bachelot
    Department of Nuclear Medicine and Endocrine Tumours, Institut Gustave Roussy, Villejuif Cedex, France
    Clin Endocrinol (Oxf) 62:376-9. 2005
    ....
  6. ncbi Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis
    Sophie Leboulleux
    Department of Nuclear Medicine and Endocrine Tumors, Institut National de la Santé et de la Recherche Médicale U605, Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif Cedex, France
    J Clin Endocrinol Metab 90:5723-9. 2005
    ..Initial treatment, performed at the Institut Gustave Roussy between 1987 and 1997, included in all patients a total thyroidectomy with central and ipsilateral en bloc neck dissection followed by radioactive iodine ablation...
  7. ncbi Functional characterization of human thyroid tissue with immunohistochemistry
    Antongiulio Faggiano
    Department of Pathology, Commissariat à l Energie Atomique LRC29V, Institut Gustave Roussy, University Paris Sud, Villejuif Cedex, France
    Thyroid 17:203-11. 2007
    ....
  8. ncbi Differential expression of galectin-3 in medullary thyroid carcinoma and C-cell hyperplasia
    Antongiulio Faggiano
    Department of Pathology, Commissariat à l Energie Atomique LRC29V, Institut Gustave Roussy, F 94805 Villejuif Cedex, France
    Clin Endocrinol (Oxf) 57:813-9. 2002
    ..The reliability of this marker in the differential diagnosis between medullary thyroid carcinoma and C-cell hyperplasia was studied by immunohistochemistry...
  9. ncbi Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy
    Renaud de Crevoisier
    Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France
    Int J Radiat Oncol Biol Phys 60:1137-43. 2004
    ..To analyze a prospective protocol combining surgery, chemotherapy (CT), and hyperfractionated accelerated radiotherapy (RT) in anaplastic thyroid carcinoma...
  10. ncbi Radiation exposure and familial aggregation of cancers as risk factors for colorectal cancer after radioiodine treatment for thyroid carcinoma
    Carole Rubino
    National Institute of Public Health and Medical Research, INSERM, Unit 605, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Int J Radiat Oncol Biol Phys 62:1084-9. 2005
    ..The aim of this study in thyroid cancer patients was to evaluate the role of familial factors in the risk of colorectal cancer and their potential interaction with radioiodine exposure...
  11. ncbi Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804
    Francesca Lombardo
    Départment de Biologie Clinique and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
    J Clin Endocrinol Metab 87:1674-80. 2002
    ..Indeed, our data should be confirmed on a larger series of V804L carriers, but may offer a balanced strategy to keep under control and prevent development of the full disease phenotype...
  12. doi Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma
    Pasqualino Malandrino
    Service de Médecine Nucléaire et de Cancérologie Endocrinienne, Institut Gustave Roussy, Universite Paris XI, 39 rue Camille Desmoulins, Villejuif Cedex, France
    Endocr Relat Cancer 17:797-807. 2010
    ..03 and <0.001). Our study suggests a prognostic role for mitotane therapy and objective response to platinum-based chemotherapy...
  13. ncbi Age-dependent variation of follicular size and expression of iodine transporters in human thyroid tissue
    Antongiulio Faggiano
    Department of Nuclear Medicine, Commissariat a l Energie Atomique, Institut Gustave Roussy, 39 rue C Demoulins, 94805 Villejuif Cedex, France
    J Nucl Med 45:232-7. 2004
    ....
  14. ncbi Expression of the apical iodide transporter in human thyroid tissues: a comparison study with other iodide transporters
    Ludovic Lacroix
    Department of Clinical Biology, Commissariat à l Energie Atomique LRC29V, Institut Gustave Roussy, 94805 Villejuif Cedex, France
    J Clin Endocrinol Metab 89:1423-8. 2004
    ..Expression of AIT protein was undetectable in most papillary carcinomas and was weak but detectable in most follicular carcinomas; it was negative in anaplastic carcinomas...
  15. ncbi PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues
    Ludovic Lacroix
    CNRS UMR 8125 Commissariat a l Energie Atomique, LRC29V, and Department of Clinical Biology, Institut Gustave Roussy, 94805 Villejuif Cedex, France
    Eur J Endocrinol 151:367-74. 2004
    ....
  16. ncbi [Cervical cystic lymph-node metastases from epidermoid carcinoma]
    Patrick Marandas
    Département de carcinologie cervico faciale, l Institut Gustave Roussy, 39 rue Camille Desmoulins 94005 Villejuif, France
    Bull Acad Natl Med 187:1117-27; discussion 1127-8. 2003
    ..Treatment consists of surgical resection of the tumor followed by external beam radiation therapy centered on the cervical lymph nodes and Waldeyer's ring. Prognosis is good, with 5-year actuarial overall survival rate of 77%...
  17. ncbi Medullary thyroid carcinoma arises in the absence of prolactin signaling
    Cécile Kedzia
    Institut National de la Sante et de la Recherche Médicale U584, Faculte de Medecine Necker, Paris, France
    Cancer Res 65:8497-503. 2005
    ..These observations suggest a possible link between the appearance of this carcinoma and the absence of prolactin signaling...
  18. ncbi Characteristics of follicular cell-derived thyroid carcinomas occurring after external radiation exposure: results of a case control study nested in a cohort
    Carole Rubino
    Unit of Cancer Epidemiology, National Institute of Health and Medical Research U521 INSERM, Villejuif, France
    Thyroid 12:299-304. 2002
    ..1-6.5), and conversely the frequency of follicular histology was similar in male cases and in male controls (OR = 0.3, 95% CI: 0.1-1.4). The risks of recurrence and of thyroid cancer related death were similar in cases and in controls...
  19. ncbi Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification
    Melania Pulcrano
    Nuclear Medicine and Endocrine Oncology, Commissariat à l Energie Atomique LRC29V, Institut Gustave Roussy and University Paris Sud, Villejuif, France
    Thyroid 17:639-46. 2007
    ....
  20. doi Galectin-3 for indeterminate thyroid cytology
    Abir Al Ghuzlan
    Lancet Oncol 9:508-10. 2008
  21. pmc Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations
    Ludovic Lacroix
    Functional Genomic Unit, Institut Gustave Roussy, Villejuif Cedex, France
    Am J Pathol 167:223-31. 2005
    ..These data identify several differentially expressed genes, such as FGD3, that may serve as potential targets of PPARgamma and as members of novel molecular pathways involved in the development of thyroid carcinomas...